Phase I Study of RO4929097, a Gamma Secretase Inhibitor of...

Journal of Clinical Oncology 2012 / 07 Vol. 30; Iss. 19

Phase I Study of RO4929097, a Gamma Secretase Inhibitor of Notch Signaling, in Patients With Refractory Metastatic or Locally Advanced Solid Tumors

Tolcher, A. W., Messersmith, W. A., Mikulski, S. M., Papadopoulos, K. P., Kwak, E. L., Gibbon, D. G., Patnaik, A., Falchook, G. S., Dasari, A., Shapiro, G. I., Boylan, J. F., Xu, Z.-X., Wang, K., Koeh
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2011.36.8282
Date:
July, 2012
File:
PDF, 206 KB
english, 2012
Conversion to is in progress
Conversion to is failed